Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors
Molecular Diversity · 2024
DOI: 10.1007/s11030-024-10807-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2024. Verfasst von Somayeh Salarinejad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Protein Kinase Inhibitors, Drug Design, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.
Abstract (Originalsprache)
Many human cancers have been associated with the deregulation of the mesenchymal-epithelial transition factor tyrosine kinase (MET) receptor, a promising drug target for anticancer drug discovery. Herein, we report the discovery of a novel structure of potent chalcone-based derivatives type II c-Met inhibitors which are comparable to Foretinib (IC50 = 14 nM) as a potent reference drug. Based on our design strategy, we also expected an anti-tubulin activity for the compounds. However, the weak inhibitory effects on microtubules were confirmed by cell cycle analyses implicated that the observed cytotoxicity against HeLa cells probably was not derived from tubulin inhibition. Compounds 14q and 14k with IC50 values of 24 nM and 45 nM, respectively, demonstrated favorable inhibition of MET kinase activity, and desirable bonding interactions in the ligand-MET enzyme complex stability in molecular docking studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
- Institute of Life and Environmental Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki, 305-8572, Japan.
- Department of Medicinal Chemistry, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Biotechnology, Faculty of Science, Bartin University, 74100, Bartin, Turkey.
- Institute of Life and Environmental Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki, 305-8572, Japan. usui.takeo.kb@u.tsukuba.ac.jp.
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Salarinejad, S., Seyfi, S., Hayashi, S., Moghimi, S., Toolabi, M., Taslimi, P., Firoozpour, L., Usui, T., & Foroumadi, A. (2024). Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors. Molecular Diversity. https://doi.org/10.1007/s11030-024-10807-x
Vancouver
Salarinejad S, Seyfi S, Hayashi S, Moghimi S, Toolabi M, Taslimi P, et al. Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors. Molecular Diversity. 2024. doi:10.1007/s11030-024-10807-x
BibTeX
@article{Salarinejad2024,
author = {Salarinejad, Somayeh and Seyfi, Soheila and Hayashi, Seiko and Moghimi, Setareh and Toolabi, Mahsa and Taslimi, Parham and Firoozpour, Loghman and Usui, Takeo and Foroumadi, Alireza},
title = {Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors},
journal = {Molecular Diversity},
year = {2024},
doi = {10.1007/s11030-024-10807-x}
}
EUVIMED